Search - tctmd.com

Displaying 1 - 20 of 50

Sort: Relevancy | Date

News Conference News THT 2025

Questioning the KCCQ: Experts Debate Its Validity as QoL Metric

Todd Neale

February 19, 2025

Presentation THT 2025

Evidence That Challenges the Validity of KCCQ as a Measure of Quality of Life in Both Blinded and Unblinded Studies

Presenter: Gregg Stone

February 13, 2025

Presentation THT 2025

Predictors of Outcomes After Inter-atrial Shunt Treatment in HFrEF and HFpEF: The RELIEVE-HF trial

Presenter: Gregg W. Stone

February 11, 2025

News Conference News ESC 2024

RESHAPE-HF2 Is a Win for MitraClip in FMR—Not Everyone’s On Board

Shelley Wood

August 31, 2024

News Daily News

The Hole Story: Interatrial Shunt Companies Are—Mostly—Pushing Ahead

Michael O'Riordan

June 20, 2024

News Opinion Editor's Corner

TCTMD’s Top 10 Most Popular Stories for April 2024

Shelley Wood

April 30, 2024

Presentation ACC 2024

Principal Results from the RELIEVE-HF Trial

Presenter: Gregg W. Stone

April 06, 2024

News Conference News ACC 2024

Interatrial Shunt Falls Short in Sham-Controlled RELIEVE-HF

Michael O'Riordan

April 06, 2024

News Daily News

Real-world MitraClip Impact in Secondary MR: Reassuring for Some, Not All

Michael O'Riordan

September 18, 2023

News Conference News THT 2023

More Early Insights Into Interatrial Shunts in HF, but Little to Focus the Field

Shelley Wood

March 24, 2023

Presentation THT 2023

5-Year COAPT Outcomes With MitraClip in FMR

Presenter: Gregg Stone

March 22, 2023

Presentation THT 2023

The PRELIEVE Trial: Responder Analysis in the HFpEF Subgroup Regarding Baseline PVR, Pacemaker and Pressure Gradients

Presenter: NULL

March 22, 2023

Presentation THT 2023

A Left Ventricular Transcatheter Repair Device for HFrEF Patients: FIH Experience With the Vsling Device

Presenter: Gregg Stone

March 21, 2023

Presentation THT 2023

Pulmonary Artery Denervation: Innovative Pulmonary Hypertension Therapies

Presenter: Gregg Stone

March 21, 2023

Presentation THT 2023

How Narrow or Broad Should Trial Enrollment Criteria Be to Achieve Clinically Interpretable Results? (STEMI vs NSTEMI; RV vs. LV vs. LV&RV Shock; AMI-CS vs Chronic HF-CS)

Presenter: Gregg Stone

March 20, 2023

Presentation THT 2023

Impella for Cardiogenic Shock: High Expectations From Ongoing Studies

Presenter: Gregg Stone

March 20, 2023

Presentation ACC 2023

5-Year Follow-Up After Transcatheter Repair of Secondary Mitral Regurgitation The COAPT Trial

Presenter: Gregg W. Stone

March 05, 2023

Presentation TCT 2022

A Left Ventricular Transcatheter Repair Device for HFrEF (Cardiac Success Vsling)

Presenter: Gregg W. Stone

September 19, 2022

Presentation TCT 2022

Reshaping the Failing Heart by Tethering the Bases of the Papillary Muscles

Presenter: Gregg Stone

September 18, 2022

News Conference News THT 2022

PA Pressure Monitoring Useful Even in Presymptomatic CHF Patients

L.A. McKeown

February 03, 2022

Advertisement

Questioning the KCCQ: Experts Debate Its Validity as QoL Metric

Evidence That Challenges the Validity of KCCQ as a Measure of Quality of Life in Both Blinded and Unblinded Studies

Predictors of Outcomes After Inter-atrial Shunt Treatment in HFrEF and HFpEF: The RELIEVE-HF trial

RESHAPE-HF2 Is a Win for MitraClip in FMR—Not Everyone’s On Board

The Hole Story: Interatrial Shunt Companies Are—Mostly—Pushing Ahead

TCTMD’s Top 10 Most Popular Stories for April 2024

Principal Results from the RELIEVE-HF Trial

Interatrial Shunt Falls Short in Sham-Controlled RELIEVE-HF

Real-world MitraClip Impact in Secondary MR: Reassuring for Some, Not All

More Early Insights Into Interatrial Shunts in HF, but Little to Focus the Field

5-Year COAPT Outcomes With MitraClip in FMR

The PRELIEVE Trial: Responder Analysis in the HFpEF Subgroup Regarding Baseline PVR, Pacemaker and Pressure Gradients

A Left Ventricular Transcatheter Repair Device for HFrEF Patients: FIH Experience With the Vsling Device

Pulmonary Artery Denervation: Innovative Pulmonary Hypertension Therapies

How Narrow or Broad Should Trial Enrollment Criteria Be to Achieve Clinically Interpretable Results? (STEMI vs NSTEMI; RV vs. LV vs. LV&RV Shock; AMI-CS vs Chronic HF-CS)

Impella for Cardiogenic Shock: High Expectations From Ongoing Studies

5-Year Follow-Up After Transcatheter Repair of Secondary Mitral Regurgitation The COAPT Trial

A Left Ventricular Transcatheter Repair Device for HFrEF (Cardiac Success Vsling)

Reshaping the Failing Heart by Tethering the Bases of the Papillary Muscles

PA Pressure Monitoring Useful Even in Presymptomatic CHF Patients

Advertisement

Advertisement

Sign In

Forgot Your Password?

Search TCTMD

CME TITLE

Sign up for our newsletter

Search TCTMD

Submit an Event

Become a PREMIUM MEMBER or LOG IN to view exclusive content

REGISTER for free or LOG IN to view this content